Cetuximab

Tax included
Cetuximab (C225) is a human IgG1 monoclonal antibody that inhibits epidermal growth factor receptor (EGFR), with a Kd of 0.201 nM for EGFR by SPR. Cetuximab has potent antitumor activity.
MedChemExpress 
HY-P9905

Data sheet

Size
Multiple sizes
Reactivity
EGFR
Application
Cancer-Kinase/protease
CAS
205923-56-4